Skip to content

In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction

Neyder Contreras, Antistio Alvíz-amador, Isabella Manzur-Villalobos

Journal of Herbmed Pharmacology April 1, 2022 DOI: 10.34172/jhp.2022.25

Summary

AI-generated from the abstract

A computational study examined how N,N-dimethyltryptamine (DMT) and a related analogue, 112814775, interact with the 5-HT1B receptor, a protein linked to depression and anxiety. Using molecular docking and 100-nanosecond molecular dynamics simulations, the analogue 112814775 showed the strongest binding to the receptor, greater conformational stability, and lower mobility compared to DMT, serotonin, and ergotamine. Free-energy calculations highlighted van der Waals, electrostatic, and nonpolar contributions. These in-silico results suggest that 112814775 may be a promising candidate for further research into treatments for psychiatric disorders involving the 5-HT1B receptor.

Study at a glance

Characteristics Computational simulation study Peer reviewed
Duration 100 ns molecular dynamics simulation
Citations 5
Key finding The DMT analogue 112814775 exhibited the lowest binding energy and superior conformational stability with the 5-HT1B receptor compared to DMT, serotonin, and ergotamine in molecular dynamics simulations.

Abstract

Introduction: The 5-HT1B receptor has a potential role in various psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder. The objective of this study was to perform docking and molecular dynamics simulation to evaluate at atomic level the behavior of N,N-dimethyltryptamine (DMT) on 5-HT1B receptor.Methods: In this study, initially, a search for DMT was performed using the PubChem database. Subsequently, molecular docking was executed using AutoDock Vina based in PyRx 0.8 with a 95% analogy. Additionally, ergotamine (ERG) and serotonin were used as control. Then, it ran a total of 100 ns molecular dynamics simulations on 5-HT1B bound with DMT, serotonin, 112814775, and ERG. Finally, pharmacokinetic prediction and IV acute toxicity for analogues and DMT were performed.Results: It was possible to show that 112814775 had the lowest binding energy with the receptor. In addition, 112814775 presented great conformational stability, low mobility, and stiffness compared to the control ligands: ERG, serotonin, and DMT subsequent dynamic analysis. With respect to the free energy calculation, contributions such as Van der Waals, electrostatics, and nonpolar interactions for all systems, were highlighted.Conclusion: 112814775 showed affinities with 5-HT1B receptor and evidenced notable behavior by molecular dynamic simulation according to root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), the radius of gyration, number of hydrogen bond, and free energy calculated. These results established the possible relevance of in-silico studies in search of DMT analogues against the 5-HT1B receptor, which may be associated with alterations such as depression and anxiety, and may become future study molecules for the treatment of this type of disorder.

Comments

No comments yet.

Log in to comment